1. Introduction {#sec1}
===============

Human beings have been living unfriendly with a lot of microorganisms that can be a potential cause of infections and diseases. In the case of bacterial infections, due to the introduction of Penicillin for treatment in the early 1940s, there was an improvement \[[@B1]\]. Majority of naturally derived antibiotics are produced from Actinomycetes \[[@B2], [@B3]\]. In this day, even though the struggle to defeat bacterial pathogens continues, bacteria are evolving ever more clever by manifesting different forms of resistance \[[@B4]\].

The current antimicrobial profile studies have been proved that, bacteria that can cause nosocomial as well as community acquired infections become pan resistant for different groups of antibiotics. Hence, this situation becomes a clinical threat to the human beings \[[@B5]--[@B13]\]. Most of the bacterial antibiotic resistance mechanisms are acquired by altering of target genes or acquisition of plasmid encoding resistance genes. These encoded genes may lead to the production of lytic enzymes, change of membrane permeability, efflux action, and hiding from the action of antibiotics \[[@B14]\].

Centers for Disease Control and Prevention (CDC) stated that antibiotic resistance is responsible for around 2 million infections, more than twenty thousand deaths and, costs \$55 billion each year in the United States \[[@B15]\]. The national pharmaceutical sales data on global antibiotic consumption (2000-2010) reveals that total antibiotic consumption grew by more than 30%. The greatest increase in antibiotics use was recorded in Low and Middle Income Countries (LMIC) \[[@B16]\].

As long as Ethiopia is one of the LMICs, antibiotic resistance is a major challenge. Yet, there is no antibiotic stewardship that helps to establish surveillance system for tracking current antibiotic use and its resistance in Ethiopia. Therefore, it is truly difficult to report bacterial antibiotic resistance pattern in Ethiopia. So, the aim of this systematic review emphasizes on the antibiotic resistance pattern of the specific bacterial isolates that can be obtained from different clinical samples in the context of Ethiopia.

2. Materials and Methods {#sec2}
========================

2.1. Eligibility Criteria {#sec2.1}
-------------------------

All available studies and data were incorporated based on the following predefined eligibility criteria:should be published and written in English,had to describe the microbial isolation, identification, and antimicrobial sensitivity test methods according to the criteria of the Clinical Laboratory Standards Institute (CLSI) and defined antimicrobial resistance range according to CLSI manual,studies which used human infection sample (isolated from a diseased individual),had to report the number of tested isolates (\>10) and the number of isolates resistant or sensitive,should be a prospective cross-sectional study.

2.2. Study Selection Procedure and Search {#sec2.2}
-----------------------------------------

The search and selection of eligible studies were shown in [Figure 1](#fig1){ref-type="fig"}. To make it more elaborative; a web-based search using PubMed, Google Scholar, Hinari, Sci Hub, Scopus, and the Directory of Open Access Journals (DOAJ) was conducted from April to May 2018 and pieces of literature potentially relevant to the study were identified. The search was performed using various keywords: Bacterial infection, antimicrobial resistance, antibiotic resistance, drug resistance, drug susceptibility, anti-bacterial resistance, Ethiopia. These key terms were used in various combinations using Boolean search technique. The search was not limited to the year of publication.

Relevant search results from the above site were individually downloaded and the reference lists of the identified studies were used to scrutinize to identify extra articles.

2.3. Data Extraction {#sec2.3}
--------------------

Essential data were extracted from eligible studies using Excel spreadsheet format prepared for this purpose and any discrepancies were resolved by the author. The data extracted from eligible studies include the name of regions, study area/city, the name of the author(s), year of the study, study design, types of specimens, numbers of patients/study participants, number of resistant isolates, resistance pattern of the isolates, and references.

3. Results {#sec3}
==========

3.1. Literature Search Results {#sec3.1}
------------------------------

The search from PubMed, Google Scholar, Hinari, Sci Hub, Scopus, and DOAJ delivered a total of 3459 studies. After amendment for duplicates, 901 endured. Of these, 780 studies were castoff, since, after a review of their titles and abstracts, they did not meet the criteria. The full texts of the remaining 121 studies were reviewed in detail. Of these, 85 studies were discarded after the full text had been reviewed for appropriate study method, sample source, number of isolates, and standard bacteriological test. Finally, 39 studies were included in the review ([Figure 1](#fig1){ref-type="fig"}).

3.2. Antibiotic Resistance for Gram-Positive Bacteria {#sec3.2}
-----------------------------------------------------

The review tries to encompass 12 gram-positive bacteria and their resistance pattern for around 12 antibiotics. It covers most of the regions which are found in Ethiopia. The resistance pattern of the isolates ranged from 0% up to 100%. GAS and GBS were highly susceptible for most of the tested antibiotics, but they have a relatively increased resistance to tetracycline. In contrast with these, MRSA was highly resistant for most of the antibiotics with a slightly increased susceptibility to gentamycin. The rest bacterial isolates have a different resistance pattern for different antibiotics and also a variable pattern from sample to sample ([Table 1](#tab1){ref-type="table"}). The average resistance pattern of gram-positive bacteria shows a cumulative antibiotic resistance pattern of bacterial isolates from different clinical cases, geographic location, and source of sample for a similar antibiotic. Still, the average resistance range of the gram-positive bacteria is similar with the detailed resistance pattern ([Figure 2](#fig2){ref-type="fig"}).

3.3. Antibiotic Resistance for Gram-Negative Bacteria {#sec3.3}
-----------------------------------------------------

Fifteen gram-negative bacteria were recovered from various specimens. Like the gram-positive bacteria, the resistance pattern ranges from 0% up to 100%. Almost all bacterial isolates were highly resistant for ampicillin. Relatively, isolates obtained from conjunctival swab were highly susceptible to different antibiotics.*Neisseria gonorrhea, S. typhimurium*, and S. Virchow were susceptible for many antibiotics.*Moraxella* spp. and S. Virchow had a similar resistance pattern for different antibiotics, even if the number of isolates varies between the two ([Table 2](#tab2){ref-type="table"}). The average resistance pattern of gram-negative bacteria shows a cumulative antibiotic resistance pattern of bacterial isolates from different clinical cases, geographic location, and source of sample for a similar antibiotic. Still, the average resistance range of the gram-negative bacteria is similar with the detailed resistance pattern ([Figure 3](#fig3){ref-type="fig"}).

3.4. Drug Resistance of*M. tuberculosis* {#sec3.4}
----------------------------------------

The overall resistance of*M. tuberculosis*for antituberculosis drugs ranges from 0% up to 32.6%. The percentage of resistance increases among previously treated tuberculosis cases. New pulmonary and extra-pulmonary cases relatively had decreased resistance for antituberculosis drugs ([Table 3](#tab3){ref-type="table"}).

4. Discussion {#sec4}
=============

Our results indicate that the antibiotic resistance pattern of both gram-negative and gram-positive bacteria varied across the studies reviewed, ranging from 0% to 100%. This variation was found depending on the type of isolate, the source of the sample, type of infection, type of antibiotics, and geographical difference used in each study.

Even though it is difficult to discuss average resistance pattern of gram positive and gram negative bacteria with a single study for various antibiotics, a study done in Nigeria revealed that gram-negative and gram-positive bacteria had a resistance pattern of 19.8%-92.3% and 10%-87%, respectively \[[@B17]\]. And also a study in Gondar, Northwest Ethiopia, showed 20%--100% and 23.5%--58.8% for gram-negative and gram-positive bacteria, respectively \[[@B18]\]. If we look at the overall resistance pattern of the above studies, it ranges from 10% to 100%. This was relatively comparable to the current review result.

A systematic review done on antimicrobial resistance in Sub-Saharan Africa (1990--2013) has been reported that Gram-positive pathogens show high prevalence of resistance to chloramphenicol, trimethoprim/sulfamethoxazole, and tetracycline and gram negative bacteria specifically the enterobacteriaceae groups show resistance to chloramphenicol, isolated from patients with a febrile illness, ranged between 31.0% and 94.2%, whereas resistance to third-generation cephalosporins ranged between 0.0% and 46.5% \[[@B13]\].

The current review revealed that majority of the bacterial isolates are resistant to commonly used antibiotics in Ethiopia \[[@B20]--[@B55]\]. The possible reason might be related to scientific justifications like the following: numerous antibacterial agents, effective previously, are no longer used today because of the rise of resistance genes in the bacterial genome \[[@B19]\]. The emergence of resistance genes can be through natural selection in the environment over a long period of time or by a spontaneous mutation in the bacterial DNA. The resistant pattern has been reported by almost all antibiotics that have been developed \[[@B20]\].

5. Limitations of the Study {#sec5}
===========================

Most of the studies done in Ethiopia do not document the antibiogram; due to this we were unable to review and extract data related to multidrug resistance.

6. Conclusions {#sec6}
==============

The main result of this study is to obtain an internationally valid reference to know the antibiotic resistance pattern in Ethiopia. The review encompasses 12 gram-positive bacteria and their resistance pattern for around 12 antibiotics. It covers most of the regions which are found in Ethiopia. The resistance pattern of the isolates ranged from 0% up to 100%. Fifteen gram-negative bacteria were recovered from various specimens. Like the gram-positive bacteria, the resistance pattern ranges from 0% up to 100%. Almost all bacterial isolates were highly resistant for ampicillin. Relatively, isolates obtained from conjunctival swab were highly susceptible to different antibiotics.*Neisseria gonorrhea*,*S. typhimurium*, and S. Virchow were susceptible for many antibiotics. The overall resistance of*M. tuberculosis* for antituberculosis drugs ranges from 0% up to 32.6%. Given the limitations of the current study, these findings should be interpreted carefully but warrant further evaluation in consequent studies.

7. Recommendations {#sec7}
==================

Our study provides evidence that majority of the bacterial isolates were resistant to commonly used antibiotics. Antibiotic resistance should be a substantial concern for Ethiopia as well as for all countries around the globe. So to alleviate such problems and to advance the effectiveness of antibiotics in Ethiopia, the government of Ethiopia as well as the international community should do the following:Prepare the guidelines for proper use of antibiotics in the health institutions.Establish antimicrobial resistance stewardship.Increase proper immunization coverage that may reduce the use of antibiotics.Implement one health policy (reduce antimicrobial use for agricultural practice and animals).Create community awareness on rational use of drugs.Make strong policy for antibiotic dispensing by drug venders.Control Hospital and community acquired infections.Ensure political commitment to meet the threat of antibiotic resistance.
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###### 

Antibiotic resistance for gram-positive bacteria.

  Microorganisms        Type of sample       Study area    No of isolates   Antibiotics and resistance (%)   Reference                                                                                     
  --------------------- -------------------- ------------- ---------------- -------------------------------- ----------- ------ ------ ------ ------ ------ ------ ------ ------ ------------ ------------ ------------
  *S. pneumoniae*       Nasal swab           GUH           96               10                               22          \-     0      \-     0      14     2      \-     32     \-           32           \[[@B21]\]
  Conjunctival swabs    West Gojjam          25            \-               44                               \-                        4      32     4                    8      8            \[[@B22]\]   
  Ocular swab           JUSH                 20                             65                                                  5      15     0      5             10     85     20           \[[@B23]\]   
  Ocular swab           HUH                  20            20               45                               0                         0      10     10            5      70     30           \[[@B24]\]   
                                                                                                                                                                                                           
  Streptococcus spp     Conjunctival swabs   West Gojjam   40                                                32.5                             15     80     0                    40           55           \[[@B22]\]
                                                                                                                                                                                                           
  *S. aureus*           Urine                Bahir Dar     10               100                              87.5                                           33.3                 50           60           \[[@B25]\]
  Blood                 Mekelle              54                             66.7                             13                 53.7   57.4          38.9          44.4   33.3                \[[@B26]\]   
  Nasal swab            Adigrat, Wukro       29            48.3             51.7                                         48.3                 17.2   37.9   17.2   62.1   37.9   55.2         \[[@B27]\]   
  Ocular swab           JUSH                 42                             21.4                                                19.1   23.8   57.1   4.8           35.7   4.8    21.4         \[[@B23]\]   
  Urine                 GUH                  28            100              100                                                        100    50     100                  50     0            \[[@B28]\]   
  Wound                 JUSH                 73            94.5             60.3                                         28.8   82.2   20.5   69.9   13.7   85     79.4   16.5                \[[@B29]\]   
  Ear discharge         HUCSH                                                                                48.5                                                         18.2                \[[@B30]\]   
  Wound                 JUSH                 47            95.7             6                                                   27.6   14.9   14.9   4             14.9   4      51           \[[@B31]\]   
  Pus*∗*                GGH                  15            80               26.7                             26.7        20     0      40     20     20     20     26.7   0      13.3         \[[@B32]\]   
  Blood                 GUH                  17            47               58.3                                                       35.3   23.5   29.4          58.8   29.4   35           \[[@B33]\]   
  Eye discharge         GUH                  13            76.9             69.2                             53.8                      23.1   30.8   15.4          46.2   46.2   61.6         \[[@B34]\]   
  Wound                 Mekelle              40            90                                                50                        90                          22.5   22.2   90           \[[@B35]\]   
  Ocular swab           HUH                  30            70               23.3                             10                        6.7    6.7    6.7           16.7   6.7    60           \[[@B24]\]   
  Ocular specimen       QOH                  40                             42.5                                                27.5          27.5   12.5   22.5   20     12.5   45           \[[@B36]\]   
  Ocular specimen       GUH                  96            92.7             7.3                              17.7                      20.8   11.5   7.3    7.3    28.1   28.1   27.1         \[[@B37]\]   
  Conjunctival swabs    West Gojjam          120           66               38                                                         30     80     13                   16.6   21           \[[@B22]\]   
  Specimen*∗*           YHMC                 194           96.4             53.1                             18.5        17.5                 18.6   31.4   11.9   53.1   13.4                \[[@B38]\]   
                                                                                                                                                                                                           
  MRSA                  Specimen*∗*          YHMC          34               100                              100         100    100                  47     82.5   53     100    38.2                      \[[@B38]\]
                                                                                                                                                                                                           
  MSSA                  Specimen*∗*          YHMC          160              95.6                             43.1        1.3    3.8                  12.5   20.6   3.1    43.1   8.1                       \[[@B38]\]
                                                                                                                                                                                                           
  *S. saprophyticus*    Urine                AAML          18                                                55.6                                           27.8   88.9   94.4   16.7         72.2         \[[@B39]\]
                                                                                                                                                                                                           
  CONS                  Blood                GUH           30               40                               53.3                             36.6   40     23.3          30     30           73.3         \[[@B33]\]
  Ocular swab           JUSH                 15                             46.6                                                6.7    26.7   73.4   0             26.7   53.3   33.3         \[[@B23]\]   
  Eye discharge         GUH                  17            76.5             70.6                             64.7                      23.5   52.9   23.5          64.7   58.8   64.7         \[[@B34]\]   
  Blood                 Mekelle              44                             81.8                             11.4               61.4   50            25            40.9   18.1                \[[@B26]\]   
  Ocular specimen       GUH                  64            89.1             23.4                             17.2                      17.2   15.6   10.9   4.7    42.2   26.6   32.8         \[[@B37]\]   
  Wound                 Mekelle              18            77.8                                              77.8                      72.3                        50     50     77.8         \[[@B35]\]   
  Ocular swab           HUH                  26            30.8             38.5                             3.8                       26.7   26.9   18.2          11.5   23.1   65.4         \[[@B24]\]   
  Conjunctival swabs    West Gojjam          110           80               41.8                                                       40     81                                              \[[@B22]\]   
  Ocular specimen       QOH                  31                             67.7                                                22.6          29     9.7    38.7   29     6.5    58.1         \[[@B36]\]   
                                                                                                                                                                                                           
  GAS                   Throat swab          Addis Ababa   52               0                                0                  0                                  0      0                   34.6         \[[@B40]\]
  Dire Dawa             16                   0             0                                                 0                                       0      0             75     \[[@B40]\]                
  Gondar                22                   0             0                                                 0                                       0      0             59.1   \[[@B40]\]                
                                                                                                                                                                                                           
  Enterococci spp       Conjunctival swabs   West Gojjam   25               100                                                                             25                   8            72           \[[@B22]\]
  Urine, wound, blood   GUH                  24            66.7                                                                 68            70.8   70.8          64            68           \[[@B41]\]   
                                                                                                                                                                                                           
  *E. faecalis*         Urine                AAML          14                                                7.1                                     73.5   7.1    7.1    85.8   0            78.6         \[[@B39]\]
  Stool, rectal swab    Jimma                34            14.7                                                                               73.5   61.8          73.5   26.5   94.1         \[[@B42]\]   
                                                                                                                                                                                                           
  *E. faecium*          Stool, rectal swab   Jimma         40               87.5                                                                     27.5   87.5          97.5   75           92.5         \[[@B42]\]
                                                                                                                                                                                                           
  GBS                   Vaginal swab         Mekelle       19               0                                                                               5.3           0      0                         \[[@B43]\]

Specimen*∗*: Nasal swab, pus from wound, ear discharge, blood, throat swab, eye swab, vaginal discharge, urethral discharge, urine, stool, sputum, CSF, and body fluids; Pus*∗*: collected from leprosy ulcer; AMP: Ampicillin; SXT: Trimethoprim-Sulfamethoxazole; AMC: Amoxicillin-Clavulanic acid; Dox: Doxycycline; CRO: Ceftriaxone; CAF: Chloramphenicol; CIP: Ciprofloxacin; DA: Clindamycin; E: Erythromycin; CN: Gentamicin; TTC: Tetracycline; FOX: Cefoxitin; GUH: Gonder University Hospital; JUSH: Jimma University Specialized Hospital; CONS: Coagulase-negative Staphylococcus; HUH: Hawassa University Hospital; GAS: Group A Streptococcus; GBS: Group B Streptococcus YHMC: Yekatit 12 Hospital Medical College; QOH: Quiha Ophthalmic Hospital; AAML: Arsho Advanced Medical laboratory; HUCSH: Hawassa University Comprehensive Specialized Hospital MRSA: Methicillin-Resistant *Staphylococcus aureus*; MSSA: Methicillin-Sensitive *Staphylococcus aureus*

###### 

Antibiotic resistance for gram-negative bacteria.

  Microorganisms                    Type of sample       Study area             No of isolates   Antibiotics and resistance (%)   Reference                                                                        
  --------------------------------- -------------------- ---------------------- ---------------- -------------------------------- ----------- ------ ------ ------ ------ ------ ------ ------ ------ ------------ ------------
  *K. pneumoniae*                   sputum, urine, pus   Harar                  57                                                65                               40     70                   61                  \[[@B44]\]
  Urine                             Bahir Dar            17                     100              50                               84.6                                    21            40     27.8   \[[@B25]\]   
  Urine                             AAML                 18                     100              66.7                                         5.6           44.4          16.7          22.2   44.4   \[[@B39]\]   
  Urine                             GUH                  28                     100              100                                                        0      100    0             100    100    \[[@B28]\]   
  Wound                             JUSH                 14                     100              85.7                                                42.9   71     85.7   35.7          64     57     \[[@B31]\]   
                                                                                                                                                                                                                   
  *H. influenza*                    Ocular swab          JUSH                                                                     92.3                      7.7    15.3   23     7.7    15.4   0      15.4         \[[@B23]\]
                                                                                                                                                                                                                   
  Klebsiella spp                    Wound                Mekelle                29               89.7                                         65.5                 86.2          37.9   44.8   27.8                \[[@B35]\]
  Conjunctival swab                 West Gojjam          20                                      28                                                         20     55     0             0      0      \[[@B22]\]   
  Urine                             AAHFH                14                                                                       0                         14.3   28.6   78.6          50            \[[@B45]\]   
                                                                                                                                                                                                                   
  *E. coli*                         Urine                Bahir Dar              64               89.1                             64.5        78.6                               64.4          27.6   66.1         \[[@B25]\]
  Blood                             Mekelle              16                                      6.7                              6.7                40     60            6.7           13.3          \[[@B26]\]   
  Urine                             GUH                  28                     66.7             66.7                                                       50     16.7   50            66.7   100    \[[@B28]\]   
  Vaginal swab                      FRH                  15                     73.3             60                                                                       20            26.7   73.3   \[[@B46]\]   
  Wound                             JUSH                 30                     76.7             20                                                  23.3   66.7   13.3   3.3           0             \[[@B29]\]   
  Wound                             JUSH                 29                     100              55                                                  44.8   62     65.5   34            51.7   79     \[[@B31]\]   
  Urine                             AAML                 135                    77.8             70.4                             45.2        22.9          34.8          50.4          28.1   69.6   \[[@B39]\]   
  Urine                             GUH                  19                     100              26.3                             36.8                      0      0      0             5.3    52.6   \[[@B18]\]   
  Urine                             StHMC                53                     79.2             22.6                                                71.7   45.3   30.2   54.7          22.6   83     \[[@B47]\]   
  Conjunctival swab                 West Gojjam          20                                      15                                                         0      35     0             20     25     \[[@B22]\]   
  Pus*∗*                            GGH                  17                     70.6             58.8                             5.9         11.8   29.4   5.9    35.3   29.4   41.2   11.8   41.2   \[[@B32]\]   
  Urine                             AAHFH                65                                                                       21.6                      24.6   32.2   56.9          53.8          \[[@B45]\]   
                                                                                                                                                                                                                   
  *P. aeruginosa*                   Urine                Bahir Dar              8                100                              71.4        75                                 0             0      40           \[[@B25]\]
  Wound                             JUSH                 74                     97.3             87.9                                                83.3   9.5    74.3   5.4           10.8          \[[@B29]\]   
  Ocular swab                       JUSH                 31                                      74.2                                                45.1   19.4   38.7   6.4           0      71     \[[@B23]\]   
  Wound                             JUSH                 11                     100              73                                                  100    63.6   82     0             18     82     \[[@B31]\]   
  Urine                             JUSH                 36                                                                                                               0             0             \[[@B48]\]   
  Wound                             Mekelle              11                     100                                               100                       100           81.8   36.4   0             \[[@B35]\]   
                                                                                                                                                                                                                   
  *Pseudomonas spp*                 Conjunctival swabs   West Gojjam            20                                                50                               15     50     0             0      20           \[[@B22]\]
                                                                                                                                                                                                                   
  *P. mirabilis*                    Urine                Bahir Dar              7                85.7                             71.4        80                                 66.7          57.1   57.1         \[[@B25]\]
  Urine                             GUH                  28                     100              100                                                        100    0      100           100    100    \[[@B28]\]   
                                                                                                                                                                                                                   
  *Proteus spp*                     Wound                JUSH                   23               91                               39                        43     65     30     17            26     74           \[[@B31]\]
  Wound                             Mekelle              15                     86.7                                              46.7                      73.3          46.7          20            \[[@B35]\]   
  Pus*∗*                            GGH                  25                     68               56                               20          12     28     8      36     32     48     32     96     \[[@B32]\]   
  Conjunctival swabs                West Gojjam          25                                      28                                                         0      76     0             8      56     \[[@B22]\]   
  Urine                             AAHFH                31                                                                       19.4                      19.4   41.9   45.9          61.3          \[[@B45]\]   
                                                                                                                                                                                                                   
  *P. vulgaris*                     Urine                Bahir Dar              3                100                              66.7        50                                 33.3          100    100          \[[@B25]\]
                                                                                                                                                                                                                   
  Enterobacter spp                  Urine                Bahir Dar              3                100                              100         100                                66.7          50     66.7         \[[@B25]\]
  Conjunctival swabs                West Gojjam          20                                      30                                                         5      40     0             20     25     \[[@B22]\]   
                                                                                                                                                                                                                   
  Citrobacter spp                   Urine                GUH                    28               69.2                             38.5                             46.2   76.9   53.8          61.5   61.5         \[[@B28]\]
  Wound                             JUSH                 18                     100              100                                                 88.9   16.7   100    11.1          33.3          \[[@B29]\]   
  Conjunctival swabs                West Gojjam          20                                      50                                                         0      50     0             0      10     \[[@B22]\]   
                                                                                                                                                                                                                   
  *Neisseria gonorrhea*             Urethral discharge   Gondar Health Center   142              80.3                             92.3                             4.2    1.4           3.5    14.1   29.6         \[[@B49]\]
  Urethral or endo-cervical swabs   Gambella hospital    21                     100                                                                         0             28.6                 100    \[[@B50]\]   
                                                                                                                                                                                                                   
  S. Typhimurium                    Stool                Addis Ababa            27               22.2                             3.7         14.8   0             3.7    0      0             0      11.1         \[[@B51]\]
                                                                                                                                                                                                                   
  S. Virchow                        Stool                Addis Ababa            21               4.8                              0           4.8    0             0      4.8    0             4.8    14.3         \[[@B51]\]
                                                                                                                                                                                                                   
  Moraxella spp                     Conjunctival swabs   West Gojjam            15                                                80                               40     53.3   40            40     40           \[[@B22]\]

GUH: Gonder University Hospital; StHMC: St. Paul\'s Hospital Millennium Medical College; AAHFH: Addis Ababa Hamlin fistula hospital; FRH: Felegehiwot Referral Hospital; GGH: Gambo General Hospital Pus*∗* = collected from leprosy ulcer

###### 

Resistance pattern of *M. tuberculosis* for anti-tuberculosis drugs.

  Type of tuberculosis case   Type of sample                            Study area      No of isolates   Antibiotics and resistance (%)   Reference                       
  --------------------------- ----------------------------------------- --------------- ---------------- -------------------------------- ----------- ------ ------ ----- ------------
  New case                    Sputum                                    BLUH            103              8.7                              1.9         7.8    0.9    \-    \[[@B52]\]
  Previously treated          Sputum                                    BLUH            18               5.6                              5.6         5.6    5.6    \-    \[[@B52]\]
  New case                    Sputum                                    JUSH            136              13.2                             2.2         8.1    5.2    \-    \[[@B53]\]
  New case                    Sputum                                    Amhara region   93               3.2                              0           20.4   0      \-    \[[@B54]\]
  New case                    Sputum                                    Amhara region   214              9.8                              3.7         6.5    5.6    3.7   \[[@B55]\]
  Previously treated          Sputum                                    Amhara region   46               32.6                             15.2        26.1   15.2   8.7   \[[@B55]\]
  EPTB                        pleural, peritoneal and synovial fluids   Addis Ababa     58               8                                21.6        5.4    2.7    \-    \[[@B56]\]

H: isoniazid; R: rifampin; S: streptomycin; E: ethambutol; P: pyrazinamide; EPTB: Extra Pulmonary Tuberculosis; JUSH: Jimma University Specialized Hospital; BLUH: Black Lion University Hospital
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